Publications

Profiling and Functional Analyses of MicroRNAs and Their Target Gene Products in Human Uterine Leiomyomas

J. Zavadil, H. Ye, Z. Liu, J. Wu, P. Lee, E. Hernando, P. Soteropoulos, GA Toruner, JJ Wei.

PLoS One, 5(8): e12362. (2010).

PMID: 20808773

A differentiation-based miRNA signature identifies leiomyosarcomas as a mesenchymal-stem cell related malignancy

L.S. Danielson, S. Menendez, C. Stephan-Otto Attolini, M.V. Guijarro, M. Bisogna, J.J. Wei, N.D. Socci, D.A. Levine, F. Michor and E. Hernando.

Am J Pathol. 177(2):908-17 (2010).

PMID: 20558575

MicroRNA signature predicts melanoma post-recurrence survival.

MF Segura, I Belitskaya-Lévy, AE Rose, J Zakrzewski, A Gaziel, D Hanniford, F Darvishian, I Osman, and E Hernando.

Clin Can Res 16(5): 1577-1586 (2010).

PMID: 2017923

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

L Wich, H Hamilton, R Shapiro, A Pavlick, RS. Berman, D Polsky, J D. Goldberg, E Hernando, P. Manga, M Krogsgaard, H Kamino, F Darvishian, S Orlow, H Ostrer, N Bhardwaj, and I Osman.

Am J Transl Res. 1: 35-43 (2009).

PMID: 1996693

Aberrant miR-182 expression promotes melanoma metastasis by repressing Foxo3 and MITF.

MF Segura, D Hanniford, S Menendez, L Reavie, X Zou, S Alvarez-Diaz, J Zakrzewski, E Blochin, A Rose, D Bogunovic, D Polsky, JJ Wei, P Lee, I Belitskaya-Levy, N Bhardwaj, I Osman, and E Hernando.

PNAS 106 (6), 1814-1819 (2009).

PMID: 19188590